Cumulative cefepime exposure in cancer patients is associated with an increased risk of ertapenem non-susceptible, meropenem susceptible Enterobacterales bacteremia. - Stabler AV; Shropshire WC; Young A; Feng C; Hwang H; Shelburne SA; Vuong NN; Borjan J (Microbiology spectrum, 2026)